Nacuda, Glory Belle D.
HRN: 05-41-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2022
AMPICILLIN 1GM (VIAL)
10/06/2022
10/13/2022
IVT
2grams
Q6h
PROM X 19hrs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes